BRADLEY HUNT: Open Payments
NPI 1780139626 · PAWTUCKET, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,600 in 56 payments from 17 companies in 2025. Trend: 2023 $248 · 2024 $378 · 2025 $1,600
Food & beverage: $1,600
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 8 | $457 |
| Sumitomo Pharma America, Inc. | 13 | $249 |
| Endo USA, Inc. | 5 | $152 |
| Ferring Pharmaceuticals Inc. | 4 | $109 |
| Merck Sharp & Dohme LLC | 3 | $91 |
| Astellas Pharma US Inc | 3 | $70 |
| Dendreon Pharmaceuticals LLC | 3 | $65 |
| Antares Pharma, Inc. | 3 | $60 |
| PROGENICS PHARMACEUTICALS, INC. | 2 | $56 |
| COLOPLAST CORP | 2 | $52 |
Products named: ERLEADA, GEMTESA, Xtandi, RYBREVANT, ADSTILADRIN, AVEED, KEYTRUDA, ORGOVYX.
Industry payments across RI — which companies pay providers there.
